Direct promoter repression by BCL11A controls the fetal to adult hemoglobin switch

Liu, Nan, Hargreaves, Victoria V., Zhu, Qian, Kurland, Jesse V., Hong, Jiyoung, Kim, Woojin, Sher, Falak, Macias-Trevino, Claudio +8 more·2018·Cell
DOI 10.1016/j.cell.2018.03.016

Cited by (477)

Items 101–200 of 477

  1. ATF4 Regulates MYB to Increase γ-Globin in Response to Loss of β-Globin
    Mandy Y. Boontanrart, Markus Schröder, Gautier Stehli, Marija Banović, Stacia K. Wyman, Rachel J. Lew, Matteo Bordi, Benjamin G. Gowen, Mark A. DeWitt, Jacob E. Corn · 2020 · Cell Reports
  2. CRISPR/Cas9-based gene-editing technology for sickle cell disease
    Liangliang Ma, Shanglun Yang, Qianya Peng, Jingping Zhang, Jing Zhang · 2023 · Gene
  3. BATF is a major driver of NK cell epigenetic reprogramming and dysfunction in AML
    Bijender Kumar, Anand Kamal Singh, Rafet Başar, Nadima Uprety, Ye Li, Huihui Fan, Ana Karen Nunez Cortes, Mecit Kaplan, Sunil Acharya, Hila Shaim et al. · 2024 · Science Translational Medicine
  4. Nuclear receptor Ftz-f1 promotes follicle maturation and ovulation partly via bHLH/PAS transcription factor Sim
    Elizabeth M Knapp, Wei Li, Vijender Singh, Jianjun Sun · 2020 · eLife
  5. Structural basis for human ZBTB7A action at the fetal globin promoter
    Yang Yang, Ren Ren, Lana C. Ly, John R. Horton, Fudong Li, Kate G R Quinlan, Merlin Crossley, Yunyu Shi, Xiaodong Cheng · 2021 · Cell Reports
  6. Lupus enhancer risk variant causes dysregulation of IRF8 through cooperative lncRNA and DNA methylation machinery
    Tian Zhou, Xinyi Zhu, Zhizhong Ye, Yongfei Wang, Chao Yao, Ning Xu, Mi Zhou, Jianyang Ma, Yuting Qin, Yiwei Shen et al. · 2022 · Nature Communications
  7. BCL11A promotes myeloid leukemogenesis by repressing PU.1 target genes
    Yoshitaka Sunami, Takashi Yokoyama, Seiko Yoshino, Tomoko Takahara, Yukari Yamazaki, Hironori Harada, Takuro Nakamura · 2021 · Blood Advances
  8. Runx factors launch T cell and innate lymphoid programs via direct and gene network-based mechanisms
    Boyoung Shin, Wen Zhou, Jue Wang, Fan Gao, Ellen V. Rothenberg · 2023 · Nature Immunology
  9. Gene editing without ex vivo culture evades genotoxicity in human hematopoietic stem cells
    Jing Zeng, My Anh Nguyen, Pengpeng Liu, Lucas Ferreira da Silva, Sébastien Levesque, Linda Yingqi Lin, David G. Justus, Karl Petri, Kendell Clement, Shaina N. Porter et al. · 2024 · Cell stem cell
  10. Elevating fetal hemoglobin: recently discovered regulators and mechanisms
    Eugene Khandros, Gerd A. Blobel · 2024 · Blood
  11. Epigenetic inactivation of ERF reactivates γ-globin expression in β-thalassemia
    Xiuqin Bao, Xinhua Zhang, Liren Wang, Zhongju Wang, Jin Huang, Qianqian Zhang, Yuhua Ye, Yongqiong Liu, Diyu Chen, Yangjin Zuo et al. · 2021 · The American Journal of Human Genetics
  12. Potential new approaches to the management of the Hb Bart’s hydrops fetalis syndrome: the most severe form of α-thalassemia
    Andrew John King, Douglas R. Higgs · 2018 · Hematology
  13. Molecular Medicine: Found in Translation
    Stuart H. Orkin · 2021 · Med
  14. A unified model of human hemoglobin switching through single-cell genome editing
    Yong Shen, Jeffrey M. Verboon, Yuannyu Zhang, Nan Liu, Yoon Jung Kim, Samantha Marglous, Satish Kumar Nandakumar, Richard A. Voit, Claudia Fiorini, Ayesha Ejaz et al. · 2021 · Nature Communications
  15. Identification of chromatin states during zebrafish gastrulation using CUT & RUN and CUT &Tag
    Bagdeser Akdogan‐Ozdilek, Katherine L. Duval, Fanju W. Meng, Patrick J. Murphy, Mary Grace Goll · 2021 · Developmental Dynamics
  16. Single-cell transcriptomic landscape of nucleated cells in umbilical cord blood
    Yi Zhao, Xiao Li, Weihua Zhao, Jingwan Wang, Jiawei Yu, Ziyun Wan, Kai Gao, Gang Yi, Wang Xie, Bingbing Fan et al. · 2019 · GigaScience
  17. MicroRNA expression patterns in HbE/β-thalassemia patients: The passwords to unlock fetal hemoglobin expression in β-hemoglobinopathies
    Sankha Subhra Das, Subhayan Das, Prasanna Kumar Byram, Motiur Rahaman, Tuphan Kanti Dolai, Anish Chatterjee, Nishant Chakravorty · 2020 · Blood Cells Molecules and Diseases
  18. Collateral damage: benchmarking off-target effects in genome editing
    Dana Carroll · 2019 · Genome biology
  19. Embryonic and fetal human hemoglobins: structures, oxygen binding, and physiological roles
    Manning, James M., Manning, Lois R., Dumoulin, Antoine, Padovan, Julio C., Chait, Brian · 2020 · Subcellular Biochemistry
  20. CRISPR/Cas-based gene editing in therapeutic strategies for beta-thalassemia
    Shujun Zeng, Shuang-Yin Lei, Chao Qu, Yue Wang, Shuzhi Teng, Ping Cheong Huang · 2023 · Human Genetics
  21. Protein-Based Degraders: From Chemical Biology Tools to Neo-Therapeutics
    Lisha Ou, Mekedlawit T. Setegne, Jeandele Elliot, Fangfang Shen, Laura M. K. Dassama · 2025 · Chemical Reviews
  22. Epigenetic Dynamics in the Function of T-Lineage Regulatory Factor Bcl11b
    Tom Sidwell, Ellen V. Rothenberg · 2021 · Frontiers in Immunology
  23. Augmenting and directing long-range CRISPR-mediated activation in human cells
    Y. Esther Tak, Joy E. Horng, Nicholas Thomas Perry, Hayley T. Schultz, Sowmya Iyer, Qiuming Yao, Luli S. Zou, Martin J. Aryee, Luca Pinello, J. Keith Joung · 2021 · Nature Methods
  24. Genetic therapies for the first molecular disease
    Phillip A. Doerfler, Akshay Sharma, Jerlym S. Porter, Yan Zheng, John F. Tisdale, Mitchell J. Weiss · 2021 · Journal of Clinical Investigation
  25. The (unusual) heuristic value of Hox gene clusters; a matter of time?
    Denis Duboule · 2022 · Developmental Biology
  26. Embryonic erythropoiesis and hemoglobin switching require transcriptional repressor ETO2 to modulate chromatin organization
    Xiang Guo, Jennifer L. Plank-Bazinet, Ivan V. Krivega, Ryan Dale, Ann Dean · 2020 · Nucleic Acids Research
  27. Heterochromatin rewiring and domain disruption-mediated chromatin compaction during erythropoiesis
    Dong Li, Fan Wu, Shuo Zhou, Xiao-Jun Huang, Xiaofei Gao, Xiang-Min Tong, Hsiang-Ying Lee · 2021 · bioRxiv
  28. DNA architectural protein CTCF facilitates subset-specific chromatin interactions to limit the formation of memory CD8+ T cells
    Sara Quon, Bing-Fei Yu, Brendan E. Russ, Kirill Tsyganov, Hongtuyet Nguyen, Clara Toma, Maximilian Heeg, James D. Hocker, J. Milner, Shane Crotty et al. · 2023 · Immunity
  29. Precision Editing as a Therapeutic Approach for β-Hemoglobinopathies
    Kiriaki Paschoudi, Evangelia Yannaki, Nikoletta Psatha · 2023 · International Journal of Molecular Sciences
  30. Editing outside the body: Ex vivo gene-modification for β-hemoglobinopathy cellular therapy
    Tolulope O. Rosanwo, Daniel E. Bauer · 2021 · Molecular Therapy
  31. Biology in balance: human diploid genome integrity, gene dosage, and genomic medicine
    J. Lupski · 2022 · Trends in Genetics
  32. Evolution of nanobodies specific for BCL11A
    Maolu Yin, Manizheh Izadi, Karin Tenglin, Thibault Viennet, Liting Zhai, Ge Zheng, Haribabu Arthanari, Laura M. K. Dassama, Stuart H. Orkin · 2023 · Proceedings of the National Academy of Sciences
  33. Promise of gene therapy to treat sickle cell disease
    Zulema G. Romero, Mark A. DeWitt, Mark C. Walters · 2018 · Expert Opinion on Biological Therapy
  34. Loss of BRD4 induces cell senescence in HSC/HPCs by deregulating histone H3 clipping
    Hui Yang, Pinpin Sui, Ying Guo, Chen Shi, Marie E. Maloof, Guo Ge, Francine Nihozeko, Caroline R. Delma, Ganqian Zhu, Peng Zhang et al. · 2023 · EMBO Reports
  35. CRISPR-Cas9 interrogation of a putative fetal globin repressor in human erythroid cells
    Jennifer E. Chung, Wendy Magis, Jonathan T. Vu, Seok‐Jin Heo, Kirmo Wartiovaara, Mark C. Walters, Ryo Kurita, Yukio Nakamura, Dario Boffelli, David I. K. Martin et al. · 2019 · PLoS ONE
  36. Research in Sickle Cell Disease: From Bedside to Bench to Bedside
    Gabriel Salinas Cisneros, Swee Lay Thein · 2021 · HemaSphere
  37. Integrating quantitative proteomics with accurate genome profiling of transcription factors by greenCUT&RUN
    Sheikh Nizamuddin, Stefanie Koidl, Tanja Bhuiyan, Tamara V. Werner, Martin Lothar Biniossek, Alexandre M. J. J. Bonvin, Silke Laßmann, H. T. Marc Timmers · 2021 · Nucleic Acids Research
  38. A ChIP-exo screen of 887 Protein Capture Reagents Program transcription factor antibodies in human cells
    William Lai, Luca Mariani, Gerson Rothschild, Edwin R. Smith, Bryan J. Venters, Thomas R. Blanda, Prashant Kumar Kuntala, Kylie Bocklund, Joshua D. Mairose, Sarah N. Dweikat et al. · 2021 · Genome Research
  39. Generation of Red Blood Cells from Human Pluripotent Stem Cells—An Update
    Shin‐Jeong Lee, Cholomi Jung, Jee Eun Oh, Sangsung Kim, Sangho Lee, Ji Yoon Lee, Young‐sup Yoon · 2023 · Cells
  40. BCL11A-deficient human erythropoiesis is impaired in vitro and after xenotransplantation into mice
    Yoonjeong Jang, Ruopeng Feng, Lance E. Palmer, Thiyagaraj Mayuranathan, Yu Yao, Kalin D. Mayberry, Sheng Zhou, Jian Xu, Jeffrey M. Gossett, Guolian Kang et al. · 2025 · Blood Advances
  41. Pathogenic BCL11A variants provide insights into the mechanisms of human fetal hemoglobin silencing
    Yong Shen, Rick Li, Kristian Teichert, Kara E. Montbleau, Jeffrey M. Verboon, Richard A. Voit, Vijay G. Sankaran · 2021 · PLoS Genetics
  42. Multidimensional profiling reveals GATA1-modulated stage-specific chromatin states and functional associations during human erythropoiesis
    Dong Li, Xin-Ying Zhao, Shuo Zhou, Qi Hu, Fan Wu, Hsiang-Ying Lee · 2023 · Nucleic Acids Research
  43. Transcription factor-mediated intestinal metaplasia and the role of a shadow enhancer
    Harshabad Singh, Davide Seruggia, Shariq Madha, Madhurima Saxena, Ankur K. Nagaraja, Zhong Wu, Jin Rong Zhou, Aaron J. Huebner, Adrianna Maglieri, Juliëtte Wezenbeek et al. · 2021 · Genes & Development
  44. An evolutionarily ancient mechanism for regulation of hemoglobin expression in vertebrate red cells
    Masato Miyata, Nynke Gillemans, Dorit Hockman, Jeroen Demmers, Jan‐Fang Cheng, Jun Hou, Matti Salminen, Christopher A. Fisher, Stephen Taylor, Richard J. Gibbons et al. · 2020 · Blood
  45. Fetal Hemoglobin Regulation in Beta-Thalassemia
    Henry Y. Lu, Stuart H. Orkin, Vijay G. Sankaran · 2023 · Hematology/Oncology Clinics of North America
  46. BCL11A intellectual developmental disorder: defining the clinical spectrum and genotype-phenotype correlations
    Angela Peron, Felice D’Arco, Kimberly A. Aldinger, Constance L. Smith‐Hicks, Christiane Zweier, Gyri Aasland Gradek, Kimberley Bradbury, Andrea Accogli, Erica Andersen, Ping Yee Billie Au et al. · 2024 · European Journal of Human Genetics
  47. Gene-centric functional dissection of human genetic variation uncovers regulators of hematopoiesis
    Satish Kumar Nandakumar, Sean McFarland, Laura Marlene Mateyka, Caleb A. Lareau, Jacob C. Ulirsch, Leif S. Ludwig, Gaurav Agarwal, J Engreitz, Bartlomiej P. Przychodzen, Marie Ellen McConkey et al. · 2019 · eLife
  48. Translational regulation and deregulation in erythropoiesis
    Alexandra Vatikioti, Elena Karkoulia, Marina Ioannou, John Strouboulis · 2019 · Experimental Hematology
  49. A modified CUT&RUN protocol and analysis pipeline to identify transcription factor binding sites in human cell lines
    Nikki R. Kong, Li Chai, Daniel Geoffrey Tenen, Mahmoud Adel Bassal · 2021 · STAR Protocols
  50. Identification and characterization of RBM12 as a novel regulator of fetal hemoglobin expression
    Aoi Wakabayashi, Maryanne Kihiu, Malini Sharma, A. Josephine Thrasher, Megan S. Saari, Mathieu Quesnel-Vallières, Osheiza Y. Abdulmalik, Scott A. Peslak, Eugene Khandros, Cheryl A. Keller et al. · 2022 · Blood Advances
  51. Limitations of mouse models for sickle cell disease conferred by their human globin transgene configurations
    Kaitly J. Woodard, Phillip A. Doerfler, Kalin D. Mayberry, Akshay Sharma, Rachel M. Levine, Jonathan S. Yen, Virginia A. Valentine, Lance E. Palmer, Marc B. Valentine, Mitchell J. Weiss · 2022 · Disease Models & Mechanisms
  52. Current landscape of gene‐editing technology in biomedicine: Applications, advantages, challenges, and perspectives
    Weilin Zhou, Jinrong Yang, Yalan Zhang, Xiaoyi Hu, Wei Wang · 2022 · MedComm
  53. Epigenetic Regulation of β-Globin Genes and the Potential to Treat Hemoglobinopathies through Epigenome Editing
    Letizia Fontana, Zoe Alahouzou, Annarita Miccio, Panagiotis Antoniou · 2023 · Genes
  54. Oncogenic YAP mediates changes in chromatin accessibility and activity that drive cell cycle gene expression and cell migration
    Maria Camila Fetiva, Franziska Liss, Dörthe Gertzmann, Julius Thomas, Benedikt Gantert, Magdalena Vogl, Nataliia Sira, Grit Weinstock, Susanne Kneitz, Carsten Patrick Ade et al. · 2023 · Nucleic Acids Research
  55. Manipulation of Developmental Gamma-Globin Gene Expression: an Approach for Healing Hemoglobinopathies
    Vigneshwaran Venkatesan, Saranya Srinivasan, Prathibha Babu, Saravanabhavan Thangavel · 2020 · Molecular and Cellular Biology
  56. Co-Regulated Genes and Gene Clusters
    Sergey V. Razin, Elena S. Ioudinkova, Omar L. Kantidze, Olga V. Iarovaia · 2021 · Genes
  57. High-throughput methods for the analysis of transcription factors and chromatin modifications: Low input, single cell and spatial genomic technologies
    Mohammad Salma, Charlotte Andrieu‐Soler, Virginie Deleuze, Éric Soler · 2023 · Blood Cells Molecules and Diseases
  58. CRISPR/Cas9-based multiplex genome editing of BCL11A and HBG efficiently induces fetal hemoglobin expression
    Yuanyuan Han, Xiaoyu Tan, Tingting Jin, Siqi Zhao, Hu Li, Wei Zhang, Ryo Kurita, Yukio Nakamura, Juan Liu, Di Li et al. · 2022 · European Journal of Pharmacology
  59. Therapeutic gene editing strategies using CRISPR-Cas9 for the β-hemoglobinopathies
    James B. Papizan, Shaina N. Porter, Akshay Sharma, Shondra M. Pruett‐Miller · 2020 · Journal of Biomedical Research
  60. 3′HS1 CTCF binding site in human β-globin locus regulates fetal hemoglobin expression
    Pamela Himadewi, Xue Qing David Wang, Fan Feng, Haley Gore, Yu-Shuai Liu, Lei Yu, R. Kurita, Yukio Nakamura, G. Pfeifer, Jie Liu et al. · 2021 · bioRxiv
  61. Developmental cell death of cortical projection neurons is controlled by a Bcl11a/Bcl6‐dependent pathway
    Christoph Wiegreffe, Tobias Wahl, Natalie Sophie Joos, Jérôme Bonnefont, P. Vanderhaeghen, P. Liu, S. Britsch · 2022 · EMBO Reports
  62. Emerging Strategies in Proteolysis-Targeting Chimeras (PROTACs): Highlights from 2022
    T. N. Rekha, Dongyun Shin · 2023 · International Journal of Molecular Sciences
  63. Matrin3 mediates differentiation through stabilizing chromatin loop-domain interactions and YY1 mediated enhancer-promoter interactions
    Tianxin Liu, Qian Zhu, Yan Kai, Trevor Bingham, Stacy Wang, Hye Ji Cha, Stuti Mehta, T. Schlaeger, Guo‐Cheng Yuan, Stuart H. Orkin · 2024 · Nature Communications
  64. Biparental contributions of the H2A.B histone variant control embryonic development in mice
    Antoine Molaro, Anna J. Wood, Derek H. Janssens, Selina M. Kindelay, Michael T. Eickbush, Steven J. Wu, Priti Singh, CHARLES H. MULLER, Steven Henikoff, Harmit Singh Malik · 2020 · PLoS Biology
  65. HRI depletion cooperates with pharmacologic inducers to elevate fetal hemoglobin and reduce sickle cell formation
    Scott A. Peslak, Eugene Khandros, Peng Huang, Xianjiang Lan, Carly Lay A. Geronimo, Jeremy D. Grevet, Osheiza Y. Abdulmalik, Zhe Zhang, Belinda M. Giardine, Cheryl A. Keller et al. · 2020 · Blood Advances
  66. A Small Key for a Heavy Door: Genetic Therapies for the Treatment of Hemoglobinopathies
    Hidde A. Zittersteijn, Cornelis L. Harteveld, Stefanie Klaver-Flores, Arjan C. Lankester, Rob C. Hoeben, Frank J. T. Staal, Manuel A.F.V. Gonçalves · 2021 · Frontiers in Genome Editing
  67. Novel lentiviral vectors for gene therapy of sickle cell disease combining gene addition and gene silencing strategies
    Mégane Brusson, Anne Chalumeau, Pierre Martinucci, Oriana Romano, Tristan Félix, Valentina Poletti, Samantha Scaramuzza, Sophie Ramadier, Cécile Masson, Giuliana Ferrari et al. · 2023 · Molecular Therapy — Nucleic Acids
  68. let-7 miRNAs repress HIC2 to regulate BCL11A transcription and hemoglobin switching
    Peng Huang, Scott A. Peslak, Vanessa Shehu, Cheryl A. Keller, Belinda M. Giardine, Junwei Shi, Ross C. Hardison, Gerd A. Blobel, Eugene Khandros · 2024 · Blood
  69. Identification of deleterious SNPs and their effects on BCL11A, the master regulator of fetal hemoglobin expression
    Sankha Subhra Das, Nishant Chakravorty · 2019 · Genomics
  70. Transcriptional silencing of fetal hemoglobin expression by NonO
    Xinyu Li, Mengxia Chen, Biru Liu, Peifen Lu, Xiang Lv, Xiang Zhao, Shuaiying Cui, Peipei Xu, Yukio Nakamura, Ryo Kurita et al. · 2021 · Nucleic Acids Research
  71. Abnormal regulation of microRNAs and related genes in pediatric β‐thalassemia
    Haiwei Wang, Meihuan Chen, Shiyi Xu, Yali Pan, Yanhong Zhang, Hailong Huang, Liangpu Xu · 2021 · Journal of Clinical Laboratory Analysis
  72. A tetramer of BCL11A is required for stable protein production and fetal hemoglobin silencing
    Ge Zheng, Maolu Yin, Stuti Mehta, I-Te Chu, Stacy Wang, Alia Alshaye, Kirstin Drainville, Altantsetseg Buyanbat, Frédérique Bienfait, Karin Tenglin et al. · 2024 · Science
  73. Reproducible immortalization of erythroblasts from multiple stem cell sources provides approach for sustainable RBC therapeutics
    Deborah E. Daniels, Daniel C. J. Ferguson, Rebecca E. Griffiths, Kongtana Trakarnsanga, Nicola M. Cogan, Katherine A. MacInnes, Kathryn E. Mordue, Tatiana Andrienko, Ivan Ferrer Vicens, Daniel Ramos Jiménez et al. · 2021 · Molecular Therapy — Methods & Clinical Development
  74. Exploring epigenetic and microRNA approaches for γ-globin gene regulation
    Athena Starlard‐Davenport, Ashley Fitzgerald, Betty S. Pace · 2021 · Experimental Biology and Medicine
  75. SEC23A rescues SEC23B-deficient congenital dyserythropoietic anemia type II
    Richard King, Zesen Lin, Ginette Balbin-Cuesta, Greggory Myers, Ann D. Friedman, Guojing Zhu, Beth M. McGee, Thomas L. Saunders, Ryo Kurita, Yukio Nakamura et al. · 2021 · Science Advances
  76. Context-dependent enhancer function revealed by targeted inter-TAD relocation
    Christopher Chase Bolt, Lucille Lopez‐Delisle, Aurélie Hintermann, Bénédicte Mascrez, Antonella Rauseo, Guillaume Andrey, Denis Duboule · 2022 · Nature Communications
  77. MicroRNA-92a-3p-mediated inhibition of BCL11A upregulates γ-globin expression and inhibits oxidative stress and apoptosis in erythroid precursor cells
    Huili Li, Ruoping Lin, Huan Li, Rilan Ou, Kaiping Wang, Junrong Lin, Chunfu Li · 2022 · Hematology
  78. Long noncoding RNA GATA2AS influences human erythropoiesis by transcription factor and chromatin landscape modulation
    Guoyou Liu, Juhyun Kim, Nicole H. Nguyen, Lecong Zhou, Ann Dean · 2024 · Blood
  79. Genetic Modifiers of Hemoglobin Expression from a Clinical Perspective in Hemoglobinopathy Patients with Beta Thalassemia and Sickle Cell Disease
    Michael D. Diamantidis, Georgia Ikonomou, Ioanna Argyrakouli, Despoina Pantelidou, Sophia Delicou · 2024 · International Journal of Molecular Sciences
  80. Direct Generation of Immortalized Erythroid Progenitor Cell Lines from Peripheral Blood Mononuclear Cells
    Abhirup Bagchi, Aneesha Nath, Vasanth Thamodaran, Smitha Ijee, Dhavapriya Palani, Vignesh Rajendiran, Vigneshwaran Venkatesan, Phaneendra Venkateswara Rao Datari, Aswin Anand Pai, Nancy B.J. Arthur et al. · 2021 · Cells
  81. Logic and lineage impacts on functional transcription factor deployment for T-cell fate commitment
    Ellen V. Rothenberg · 2021 · Biophysical Journal
  82. Single Nucleotide Polymorphisms in XMN1-HBG2, HBS1L-MYB, and BCL11A and Their Relation to High Fetal Hemoglobin Levels That Alleviate Anemia
    Siti Nur Nabeela A’ifah Mohammad, Salfarina Iberahim, Wan Suriana Wan Ab Rahman, Mohd Nazri Hassan, Hisham Atan Edinur, Maryam Azlan, Zefarina Binti Zulkafli · 2022 · Diagnostics
  83. Nonclinical evaluation of HBG1/2 and BCL11A as genome-editing targets for the treatment of β-hemoglobinopathies
    Tusneem Janoudi, Mrunali Jagdale, Meng Wu, Sanjana Gorlla, Peisheng Zhang, Ying Shao, Li Li, Sheryl R. Bowley, Eugenio Marco, Kai-Hsin Chang · 2024 · Blood Advances
  84. Small molecule therapeutics to treat the β-globinopathies
    Lei Yu, Greggory Myers, James Douglas Engel · 2020 · Current Opinion in Hematology
  85. Molecular simulation studies on B-cell lymphoma/leukaemia 11A (BCL11A).
    Sayed AbdulAzeez · 2019 · Europe PMC (PubMed Central)
  86. Induction of therapeutic levels of HbF in genome‐edited primary β039‐thalassaemia haematopoietic stem and progenitor cells
    Maura Mingoia, Cristian Antonio Caria, Lin Ye, Isadora Asunis, Maria Franca Marongiu, Laura Manunza, Maria Carla Sollaino, Jiaming Wang, Annalisa Cabriolu, Ryo Kurita et al. · 2020 · British Journal of Haematology
  87. TET proteins regulate T cell and iNKT cell lineage specification in a TET2 catalytic dependent manner
    Tarmo Äijö, Dimitris Theofilatos, Meng Cheng, Matthew D. Smith, Yue Xiong, Albert S. Baldwin, Ageliki Tsagaratou · 2022 · Frontiers in Immunology
  88. PU.1 and MYC transcriptional network defines synergistic drug responses to KIT and LSD1 inhibition in acute myeloid leukemia
    Brittany M. Curtiss, Jake VanCampen, Jommel Macaraeg, Garth Kong, Akram Taherinasab, Mitsuhiro Tsuchiya, William M. Yashar, Yiu Huen Tsang, Wesley R. Horton, Daniel J. Coleman et al. · 2022 · Leukemia
  89. Molecular basis of polycomb group protein-mediated fetal hemoglobin repression
    Kunhua Qin, Xianjiang Lan, Peng Huang, Megan S. Saari, Eugene Khandros, Cheryl A. Keller, Belinda M. Giardine, Osheiza Y. Abdulmalik, Junwei Shi, Ross C. Hardison et al. · 2023 · Blood
  90. Recent advancements in gene therapy for sickle cell disease and β-thalassemia
    Lushen Li, Pankaj Kumar Mandal · 2024 · Frontiers in Hematology
  91. An evolving understanding of multiple causal variants underlying genetic association signals
    Erping Long, Jacob Williams, Haoyu Zhang, Jiyeon Choi · 2025 · The American Journal of Human Genetics
  92. Episomal vectors based on S/MAR and the β-globin Replicator, encoding a synthetic transcriptional activator, mediate efficient γ-globin activation in haematopoietic cells
    Eleana F. Stavrou, Emannuouil Simantirakis, Meletios Verras, Carlos F. Barbas, George Vassilopoulos, Kenneth R. Peterson, Aglaia Athanassiadou · 2019 · Scientific Reports
  93. A Novel de novo Frameshift Mutation in the BCL11A Gene in a Patient with Intellectual Disability Syndrome and Epilepsy
    Georg Christoph Korenke, Björn Schulte, Saskia Biskup, John Neidhardt, Marta Owczarek‐Lipska · 2020 · Molecular Syndromology
  94. In The Blood: Connecting Variant to Function In Human Hematopoiesis
    Satish Kumar Nandakumar, Xiaotian Liao, Vijay G. Sankaran · 2020 · Trends in Genetics
  95. Molecular analysis of the erythroid phenotype of a patient with BCL11A haploinsufficiency
    Marja W. Wessels, Marjon H. Cnossen, Thamar B. van Dijk, Nynke Gillemans, K. L. Juliëtte Schmidt, Kirsten van Lom, Divya S. Vinjamur, Steven M. Coyne, Ryo Kurita, Yukio Nakamura et al. · 2021 · Blood Advances
  96. Epigenomic analysis of KLF1 haploinsufficiency in primary human erythroblasts
    Steven Heshusius, Laura Grech, Nynke Gillemans, Rutger W. W. Brouwer, Alexander T. den Dekker, Wilfred F. J. van IJcken, Benjamin Nota, Alex E. Felice, Thamar B. van Dijk, Marieke v. Lindern et al. · 2022 · Scientific Reports
  97. Targeting fetal hemoglobin expression to treat β hemoglobinopathies
    Martin H. Steinberg · 2022 · Expert Opinion on Therapeutic Targets
  98. The Fetal-to-Adult Hemoglobin Switch — Mechanism and Therapy
    Stuart H. Orkin · 2025 · New England Journal of Medicine
  99. CUT&RUN for Chromatin Profiling in Caenorhabditis elegans
    Felicity J. Emerson, Siu Sylvia Lee · 2022 · Current Protocols
  100. Site-specific genome editing in treatment of inherited diseases: possibility, progress, and perspectives
    Chao Huang, Qing Li, Jinsong Li · 2022 · Medical Review